Back
Lumos Pharma Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
38
LUMO
Lumos Pharma
Last Price:
3.95
Seasonality Move:
-11.54%
Sell
50
NBY
NovaBay Pharmaceuticals
Last Price:
0.70
Seasonality Move:
-18.64%
Sell
38
Lumos Pharma (LUMO)
is a Sell
Is Lumos Pharma a Buy, Sell or Hold?
- The current Lumos Pharma [LUMO] share price is $3.82. The Score for LUMO is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- LUMO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.73. The Score for NBY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LUMO Stock Price Chart
What is Lumos Pharma's stock price today?
-
The Lumos Pharma share price today is $3.82
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LUMO is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.73
The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
LUMO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.23 | Buy |
Relative Strength Index (14 RSI): | 56.87 | Buy |
Chaikin Money Flow: | -22854 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.6 - 4) | Buy |
Bollinger Bands (100): | (1.85 - 3.41) | Buy |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 59.35 | Buy |
Chaikin Money Flow: | 367837 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.44 - 0.64) | Buy |
Bollinger Bands (100): | (0.46 - 3.26) | Sell |
LUMO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.88 | Sell |
20-day SMA: | 3.82 | Sell |
50-day SMA: | 2.93 | Buy |
200-day SMA: | 2.77 | Buy |
8-day EMA: | 3.88 | Sell |
20-day EMA: | 3.72 | Buy |
50-day EMA: | 3.23 | Buy |
200-day EMA: | 2.93 | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.64 | Buy |
20-day SMA: | 0.54 | Buy |
50-day SMA: | 0.71 | Buy |
200-day SMA: | 3.55 | Sell |
8-day EMA: | 0.66 | Buy |
20-day EMA: | 0.6 | Buy |
50-day EMA: | 0.91 | Sell |
200-day EMA: | 7.97 | Sell |
Lumos Pharma Earnings Growth & LUMO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.33 per share, an increase this year of $0.36 per share, and an increase next year of $1.26 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Lumos Pharma Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |